{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Naftifine+hydrochloride+2%25", "query": { "intervention": "Naftifine hydrochloride 2%" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 8, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-01T12:47:24.926Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00253305", "title": "Topical Gel Anti-Fungal Agent for Tinea Unguium", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Onychomycosis" ], "interventions": [ { "name": "Organogel of naftifine, 2%", "type": "DRUG" }, { "name": "Organogel of terbinafine, 2%", "type": "DRUG" }, { "name": "Organogel of naftifine, 6%", "type": "DRUG" }, { "name": "Organogel of terbinafine, 6%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MediQuest Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 75, "start_date": "2005-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2007-05-30", "last_synced_at": "2026-10-01T12:47:24.926Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Miami Beach, Florida + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00253305" }, { "nct_id": "NCT01289015", "title": "Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tinea Pedis" ], "interventions": [ { "name": "NAFT-600 ( naftin 2 % gel )", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 855, "start_date": "2011-02", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2013-09-26", "last_synced_at": "2026-10-01T12:47:24.926Z", "location_count": 22, "location_summary": "Phoenix, Arizona • San Diego, California • San Francisco, California + 19 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01289015" }, { "nct_id": "NCT02466867", "title": "An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tinea Corporis" ], "interventions": [ { "name": "Naftin® Cream, 2% (younger pediatric cohort)", "type": "DRUG" }, { "name": "Naftin® Cream, 2% (older pediatric cohort)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 27, "start_date": "2014-01", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-01T12:47:24.926Z", "location_count": 1, "location_summary": "College Station, Texas", "locations": [ { "city": "College Station", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02466867" }, { "nct_id": "NCT01290341", "title": "Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tinea Pedis" ], "interventions": [ { "name": "NAFT-600 (naftin 2 % gel)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 860, "start_date": "2011-02", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2013-09-26", "last_synced_at": "2026-10-01T12:47:24.926Z", "location_count": 23, "location_summary": "Tucson, Arizona • Encino, California • San Diego, California + 19 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Encino", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Longmont", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01290341" }, { "nct_id": "NCT02227290", "title": "Pediatric Subjects With Tinea Corporis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tinea Corporis" ], "interventions": [ { "name": "Naftin Cream", "type": "DRUG" }, { "name": "Placebo Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 230, "start_date": "2014-08", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-01T12:47:24.926Z", "location_count": 14, "location_summary": "Tucson, Arizona • Encino, California • Fremont, California + 10 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Encino", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02227290" }, { "nct_id": "NCT05363449", "title": "Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Tinea Cruris", "Tinea Pedis" ], "interventions": [ { "name": "UHE-103 Cream", "type": "DRUG" }, { "name": "Naftin (naftifine hydrochloride) Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2022-02-17", "completion_date": "2023-11-14", "has_results": false, "last_update_posted_date": "2024-04-10", "last_synced_at": "2026-10-01T12:47:24.926Z", "location_count": 5, "location_summary": "San Diego, California • Thousand Oaks, California • Austin, Texas + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Thousand Oaks", "state": "California" }, { "city": "Austin", "state": "Texas" }, { "city": "College Station", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05363449" }, { "nct_id": "NCT02633813", "title": "BE Study of Naftifine HCL", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tinea Pedis" ], "interventions": [ { "name": "Naftifine hydrochloride 2%", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Naftin® 2% (Naftifine hydrochloride 2%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genzum Life Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 693, "start_date": "2015-03", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2017-05-11", "last_synced_at": "2026-10-01T12:47:24.926Z", "location_count": 12, "location_summary": "Brandon, Florida • Miami, Florida • Miramar, Florida + 6 more", "locations": [ { "city": "Brandon", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02633813" }, { "nct_id": "NCT01712360", "title": "Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tinea Pedis", "Tinea Cruris" ], "interventions": [ { "name": "NAFT500 (pediatric)", "type": "DRUG" }, { "name": "NAFT600 (pediatric)", "type": "DRUG" }, { "name": "NAFT500 (adult)", "type": "DRUG" }, { "name": "NAFT600 (adult)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 56, "start_date": "2012-10", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2016-07-14", "last_synced_at": "2026-10-01T12:47:24.926Z", "location_count": 2, "location_summary": "Austin, Texas • College Station, Texas", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "College Station", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01712360" } ] }